Clinicopathological significance and potential drug target of RUNX3 in breast cancer
Ying-Ying Yu,1 Chao Chen,2 Fan-fei Kong,2 Wei Zhang1 1Obstetrics and Gynecology Hospital, Fudan University, Shanghai, People’s Republic of China; 2Department of Gynecology, Shanghai First Maternity and Infant Hospital Affiliated to TongJi University, Shanghai, People’s Republic o...
Saved in:
Main Authors: | Yu YY (Author), Chen C (Author), Kong FF (Author), Zhang W (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
by: Xu L, et al.
Published: (2015) -
Clinicopathological significance and potential drug target of T-cadherin in NSCLC
by: Wang Z, et al.
Published: (2014) -
The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
by: Su Y, et al.
Published: (2015) -
Clinicopathological significance of CXCR4 in non-small cell lung cancer
by: Zhou X, et al.
Published: (2015) -
Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review
by: Huang R, et al.
Published: (2015)